| RS1555461695 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555461697 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1555461704 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461727 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461733 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555461765 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461777 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461779 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461788 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1555461790 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461796 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461809 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group N |
| RS1555461825 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1555461835 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555461846 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1555461868 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555461870 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Familial cancer of breast |
| RS1555461872 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1555461875 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555462026 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555462031 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555462076 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1555462145 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS1555462184 |
AP4E1
|
Health Risk |
Likely pathogenic |
Stuttering, familial persistent |
| RS1555462347 |
USP7
|
Health Risk |
Likely pathogenic |
USP7-related disorder, Hao-Fountain syndrome |
| RS1555462433 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555462438 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555462463 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1555463008 |
IGF1R
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555464774 |
AP3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 48 |
| RS1555465642 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS1555465891 |
SRCAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS1555465917 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS1555465928 |
SRCAP
|
Health Risk |
Pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS1555465942 |
SRCAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Floating-Harbor syndrome |
| RS1555465963 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS1555465966 |
SRCAP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555466178 |
SRCAP
|
Health Risk |
Likely pathogenic |
— |
| RS1555466999 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Nephrocalcinosis, Nephrolithiasis |
| RS1555467052 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS1555467473 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS1555467557 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Inborn genetic diseases |
| RS1555468374 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis |
| RS1555468482 |
ERCC4
|
Health Risk |
Pathogenic |
Cockayne syndrome, Fanconi anemia complementation group Q |
| RS1555468632 |
CLN3
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Neuronal ceroid lipofuscinosis 3 |
| RS1555468634 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 3, Retinitis pigmentosa |
| RS1555468695 |
CLN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Neuronal ceroid lipofuscinosis |
| RS1555468920 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1555469089 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS1555469159 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis |
| RS1555469452 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS1555469477 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis |
| RS1555469732 |
TELO2
|
Health Risk |
Likely pathogenic |
— |
| RS1555470631 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555471077 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555471086 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1555471098 |
CREBBP
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS1555471323 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555471336 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1555471355 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1555471385 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1555471394 |
CREBBP
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Menke-Hennekam syndrome 1 |
| RS1555471813 |
CREBBP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555471874 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1555471931 |
CREBBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555471981 |
MEIS2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Cardiac malformation |
| RS1555472161 |
HEXA
|
Health Risk |
Pathogenic/Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472262 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472270 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472296 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472406 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472432 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472440 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472543 |
HEXA
|
Health Risk |
Conflicting classifications of pathogenicity |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472553 |
HEXA
|
Health Risk |
Pathogenic/Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555472691 |
MEIOB
|
Health Risk |
Pathogenic |
Spermatogenic failure 22, Spermatogenic failure 22 |
| RS1555472931 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1555472938 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555473070 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555473105 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555473122 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555473138 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555473349 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1555473491 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Cervical cancer |
| RS1555473499 |
CREBBP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555473668 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1555473890 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1555474009 |
IFT140
|
Health Risk |
Pathogenic |
Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene, Retinitis pigmentosa 80 |
| RS1555475106 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1555475120 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1555475250 |
CREBBP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555475275 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1555475283 |
STUB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Spinocerebellar ataxia 48 |
| RS1555475319 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1555475334 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1555475342 |
SALL1
|
Health Risk |
Pathogenic |
Townes syndrome, Townes syndrome |
| RS1555475352 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555475375 |
STUB1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS1555475414 |
SALL1
|
Health Risk |
Conflicting classifications of pathogenicity |
SALL1-related disorder, Townes syndrome |
| RS1555475434 |
HCN4
|
Health Risk |
Likely pathogenic |
Brugada syndrome 8, Brugada syndrome 8 |